Pascal Biosciences Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pascal Biosciences are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pascal Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Pascal Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Pascal |
Pascal Biosciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Pascal Biosciences on October 2, 2025 and sell it today you would earn a total of 100.00 from holding Pascal Biosciences or generate -100.0% return on investment over 90 days. Pascal Biosciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Pascal, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pascal Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pascal Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Pascal Biosciences, and traders can use it to determine the average amount a Pascal Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PSCBF |
Based on monthly moving average Pascal Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pascal Biosciences by adding Pascal Biosciences to a well-diversified portfolio.
Pascal Biosciences Fundamentals Growth
Pascal OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Pascal Biosciences, and Pascal Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pascal OTC Stock performance.
| Return On Asset | -2.81 | |||
| Current Valuation | 869.66 K | |||
| Shares Outstanding | 65.59 M | |||
| Price To Book | 317.13 X | |||
| EBITDA | (1.07 M) | |||
| Cash And Equivalents | 16.91 K | |||
| Total Debt | 215.65 K | |||
| Debt To Equity | 8.83 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (614.93 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 155.19 K | |||
Things to note about Pascal Biosciences performance evaluation
Checking the ongoing alerts about Pascal Biosciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Pascal Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pascal Biosciences is not yet fully synchronised with the market data | |
| Pascal Biosciences has some characteristics of a very speculative penny stock | |
| Pascal Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pascal Biosciences has accumulated 215.65 K in total debt with debt to equity ratio (D/E) of 8.83, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pascal Biosciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pascal Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pascal Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pascal Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pascal to invest in growth at high rates of return. When we think about Pascal Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.09 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pascal Biosciences has accumulated about 16.91 K in cash with (614.93 K) of positive cash flow from operations. |
- Analyzing Pascal Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pascal Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Pascal Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pascal Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pascal Biosciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Pascal Biosciences' otc stock. These opinions can provide insight into Pascal Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Pascal Biosciences information on this page should be used as a complementary analysis to other Pascal Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Pascal OTC Stock
If you are still planning to invest in Pascal Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pascal Biosciences' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |